Raul Parra Jr. - 07 Nov 2024 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CFO AND TREASURER
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
07 Nov 2024
Net transactions value
-$345,624
Form type
4
Filing time
12 Nov 2024, 06:00:07 UTC
Previous filing
07 Nov 2024
Next filing
03 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Options Exercise $202,163 +5,361 +33% $37.71 21,722 07 Nov 2024 Direct
transaction MMSI Common Stock, No Par Value Sale $547,787 -5,361 -25% $102.18 16,361 07 Nov 2024 Direct F2
holding MMSI Common Stock, No Par Value 2,770 07 Nov 2024 By 401(k) Plan F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -5,361 -50% $0.000000 5,361 07 Nov 2024 Common Stock 5,361 $37.71 Direct F3
holding MMSI Non-qualified stock options (right to buy) 9,681 07 Nov 2024 Common Stock 9,681 $56.25 Direct F4
holding MMSI Non-qualified stock options (right to buy) 14,570 07 Nov 2024 Common Stock 14,570 $65.03 Direct F5
holding MMSI Non-qualified stock options (right to buy) 13,576 07 Nov 2024 Common Stock 13,576 $70.58 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents plan holdings as of 11/07/2024.
F2 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.17 to $102.25, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 Becomes exercisable in equal annual installments of 25% commencing 02/26/2021.
F4 Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
F5 Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.
F6 Becomes exercisable in equal annual installments of 25% commencing on 02/28/2024.